MGC Diagnostics (MGCD) Reports Q1 Loss of $0.13/Share

MGC Diagnostics (NASDAQ: MGCD) reported Q1 EPS of ($0.13), versus ($0.06) reported last year. Revenue for the quarter came in at $8.9 million, versus $6.3 million reported last year.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Citi raises Huya price target to $4.60 from $4.40
• Home Depot CEO takes medical leave 6 days before Q2 earnings